GrantRichardSeegerMD, MHA, DABR

Principal investigator at Altru for the Alliance for Clinical Trials in Oncology research group. Clinical Assistant Professor in the Internal Medicine and Radiology Departments at the University of North Dakota.

Join to view full profile

Dr. Seeger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Seeger's full profile

Already have an account?

Office
960 S Columbia Rd
Grand Forks, ND 58201
Phone+1 701-780-5860

Fax+1 701-780-1942
Is this information wrong?

Education & Training

University of Texas Medical Branch HospitalsResidency, Radiation Oncology, 2005 - 2009
University of MinnesotaInternship, Internal Medicine, 2004 - 2005
University of North Dakota School of Medicine and Health SciencesClass of 2004

Certifications & Licensure

MI State Medical License 2009 - 2026
ND State Medical License 2009 - 2025
TX State Medical License 2007 - 2024
MN State Medical License 2010 - 2024
CA State Medical License 2009 - 2024
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

I Am Altru Award Altru Health System, 2016
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013
Conquer Cancer Foundation Clinical Trials Participation Award American Society of Clinical Oncology, 2012

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2006 Mar 24
Completed
Phase 1, Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients Start of enrollment: 2007 Jul 01
Completed
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy Start of enrollment: 2008 Jun 15
Completed
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Start of enrollment: 2009 Sep 01
Recruiting
Phase 3
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Active, not recruiting
Phase 2
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2012 Nov 01
Completed
Phase 1, Phase 2
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy Start of enrollment: 2014 Apr 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

7 citations
N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.
Terence T. Sio, M.J. Blanchard, Paul J. Novotny, Samir H. Patel, Jean-Claude M. Rwigema, Levi Pederson, Lisa A. McGee, Mauricio E. Gamez, Grant R. Seeger, James A. Mar...> ;Mayo Clinic Proceedings. 2019 Sep 1
N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Charles L Loprinzi, Daniel G Petereit, Matthew J Iott, Rex B Mowat, Grant R Seeger, Robert C Miller, James A Martenson> ;International Journal of Radiation Oncology • Biology • Physics.

Journal Articles

N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Robert C. Miller, MD, Daniel G. Petereit, MD, Jeff A. Sloan, PhD, Heshan Liu, MS, James A. Martenson, MD, James D. Bearden III, MD, Ronald Sapiente, MD, Grant R. Seege..., International journal of radiation oncology, biology, physics, 7/15/2016
Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.
Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL., J Natl Cancer Inst., 8/21/2013

Abstracts/Posters

Primary and Secondary Endpoint Analysis of N08C9 (Alliance): A Phase 3 Randomized Trial of Sulfasalazine Versus Placebo in the Prevention of Acute Radiation Enteritis
Robert C. Miller, MD, Daniel G. Petereit, MD, Jeff A. Sloan, PhD, Heshan Liu, MS, James A. Martenson, MD, James D. Bearden III, MD, Ronald Sapiente, MD, Grant R. Seege..., International journal of radiation oncology, biology, physics, https://doi.org/10.1016/j.ijrobp.2014.05.476, 9/1/2014